ERBB2 and breast carcinoma: Brachmann et al. reported that BEZ235 could induce cell apoptosis in HER2-positive breast cancer cells [15], but in our present study, BEZ235 treatment failed to induce apoptosis in NCI-N87 and SNU216 cells (Additional file 1: Figure S2).